BioAge Labs Inc.
NASDAQ: BIOA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kristen Fortney
- Employees
- 61
- Headquarters
- Emeryville, United States
- IPO year
- 2024
- Market cap
- $859.5M
- Website
- https://bioagelabs.com
Loading BIOA…
Loading profile data…Frequently asked questions about BIOA
What does BioAge Labs Inc. (BIOA) do?
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally...
Where does BIOA trade?
BioAge Labs Inc. (BIOA) trades on the NASDAQ.
What sector is BIOA in?
BioAge Labs Inc. (BIOA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BioAge Labs Inc.?
Kristen Fortney is the chief executive officer of BioAge Labs Inc. (BIOA).
Where is BioAge Labs Inc. headquartered?
BioAge Labs Inc. is headquartered in United States.
Does BIOA pay a dividend?
BioAge Labs Inc. (BIOA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOA go public?
BioAge Labs Inc. (BIOA) completed its initial public offering in 2024.